Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis
- 19 July 2012
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 23 (9), 925-929
- https://doi.org/10.1111/j.1540-8167.2012.02350.x
Abstract
ICD Shocks in Cardiac Sarcoidosis. Background: An implantable cardioverter defibrillator (ICD) is indicated for some patients with cardiac sarcoidosis (CS) for prevention of sudden death. However, there are little data regarding the event rates of ICD therapies in these patients. We sought to identify the incidence and characteristics of ICD therapies in this patient population. Methods: We performed a cohort study of patients with ICDs at 3 institutions. Cases were those patients with CS and an ICD implanted for primary or secondary prevention of sudden death. Additionally, we included a comparison with historical controls of ICD therapy rates reported in clinical trials evaluating the ICD for primary and secondary prevention of sudden death. Results: Of the 112 CS subjects identified, 36 (32.1%) received appropriate therapies for ventricular tachyarrhythmias (VT) over a mean follow-up period of 29.2 months. VT storm (>3 episodes in 24 hours) occurred in 16 (14.2%) CS subjects. Inappropriate therapies occurred in 13 CS subjects (11.6%). Covariates associated with appropriate ICD therapies included left ventricular ejection fraction (LVEF) Conclusions: In our cohort of patients with CS and ICDs, almost one-third receive appropriate therapies. This may be due to a myocardial inflammatory process leading to increased triggered activity and subsequent scarring leading to reentrant tachyarrhythmias. Adjusted predictors of ICD therapies in this population include left or right ventricular dysfunction. (J Cardiovasc Electrophysiol, Vol. 23, pp. 925-929, September 2012)Keywords
This publication has 10 references indexed in Scilit:
- Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular TachycardiaCirculation, 2010
- Strategic Programming of Detection and Therapy Parameters in Implantable Cardioverter-Defibrillators Reduces Shocks in Primary Prevention PatientsJournal of the American College of Cardiology, 2008
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesCirculation, 2008
- Prophylactic Catheter Ablation for the Prevention of Defibrillator TherapyNew England Journal of Medicine, 2007
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Cardiac SarcoidosisMedicine, 2004
- Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular CardiomyopathyCirculation, 2004
- Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.Cell Metabolism, 1978
- Sarcoidosis of the heartAmerican Journal Of Medicine, 1977
- Myocardial degeneration in cardiac sarcoidosisAmerican Heart Journal, 1965